ACURATE Neo™ AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic Stenosis
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT02909556
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- Symetis SA
- Registry
-
NCT02909556
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Denmark, Germany, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT02909556. Allocation not applicable; no masking; primary purpose treatment. Start 2016-12-16 (actual); primary completion 2018-01-24 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ACURATE Neo™ AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic Stenosis
- Condition
- Aortic Stenosis
- Intervention (Device)
- Transcatheter aortic valve replacement
- Lead sponsor
- Symetis SA
Record details
- Record id
cardio:ct-nct02909556- Content hash
5f4766e4645588c727daad3856e2e83054bc921b750c7d8a4f5f1474091c05e3